Logo image of C1V.DE

MVISE AG (C1V.DE) Stock Fundamental Analysis

FRA:C1V - Deutsche Boerse Ag - DE0006204589 - Common Stock - Currency: EUR

0.63  -0.01 (-0.79%)

Fundamental Rating

1

Overall C1V gets a fundamental rating of 1 out of 10. We evaluated C1V against 72 industry peers in the IT Services industry. Both the profitability and financial health of C1V have multiple concerns. C1V does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

C1V had negative earnings in the past year.
C1V had a negative operating cash flow in the past year.
In the past 5 years C1V always reported negative net income.
Of the past 5 years C1V 4 years had a positive operating cash flow.
C1V.DE Yearly Net Income VS EBIT VS OCF VS FCFC1V.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

The Return On Assets of C1V (-32.76%) is worse than 84.72% of its industry peers.
Looking at the Return On Equity, with a value of -64.73%, C1V is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA -32.76%
ROE -64.73%
ROIC N/A
ROA(3y)-20.29%
ROA(5y)-17.95%
ROE(3y)-8180.77%
ROE(5y)-4959.83%
ROIC(3y)N/A
ROIC(5y)N/A
C1V.DE Yearly ROA, ROE, ROICC1V.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K -20K

1.3 Margins

The Gross Margin of C1V (65.29%) is comparable to the rest of the industry.
C1V's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for C1V so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.92%
GM growth 5Y-3.16%
C1V.DE Yearly Profit, Operating, Gross MarginsC1V.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

C1V does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, C1V has about the same amount of shares outstanding.
The number of shares outstanding for C1V has been increased compared to 5 years ago.
C1V has a worse debt/assets ratio than last year.
C1V.DE Yearly Shares OutstandingC1V.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
C1V.DE Yearly Total Debt VS Total AssetsC1V.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.34, we must say that C1V is in the distress zone and has some risk of bankruptcy.
C1V has a Altman-Z score of -0.34. This is amonst the worse of the industry: C1V underperforms 80.56% of its industry peers.
C1V has a Debt/Equity ratio of 0.73. This is a neutral value indicating C1V is somewhat dependend on debt financing.
C1V has a Debt to Equity ratio (0.73) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z -0.34
ROIC/WACCN/A
WACC5.96%
C1V.DE Yearly LT Debt VS Equity VS FCFC1V.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

C1V has a Current Ratio of 0.99. This is a bad value and indicates that C1V is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.99, C1V is doing worse than 66.67% of the companies in the same industry.
C1V has a Quick Ratio of 0.99. This is a bad value and indicates that C1V is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, C1V is doing worse than 65.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.97
C1V.DE Yearly Current Assets VS Current LiabilitesC1V.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for C1V have decreased strongly by -85.64% in the last year.
C1V shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.35%.
Measured over the past years, C1V shows a decrease in Revenue. The Revenue has been decreasing by -9.08% on average per year.
EPS 1Y (TTM)-85.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-685.02%
Revenue 1Y (TTM)-25.35%
Revenue growth 3Y-9.67%
Revenue growth 5Y-9.08%
Sales Q2Q%-40.06%

3.2 Future

C1V is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.78% yearly.
C1V is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.34% yearly.
EPS Next Y-300%
EPS Next 2Y-41.42%
EPS Next 3Y-9.14%
EPS Next 5Y20.78%
Revenue Next Year-32.64%
Revenue Next 2Y-15.43%
Revenue Next 3Y-8.31%
Revenue Next 5Y-1.34%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
C1V.DE Yearly Revenue VS EstimatesC1V.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5M 10M 15M 20M
C1V.DE Yearly EPS VS EstimatesC1V.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.1 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

C1V reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
C1V.DE Price Earnings VS Forward Price EarningsC1V.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
C1V.DE Per share dataC1V.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

C1V's earnings are expected to decrease with -9.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-9.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for C1V!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MVISE AG

FRA:C1V (3/26/2025, 7:00:00 PM)

0.63

-0.01 (-0.79%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.77%
Ins Owner ChangeN/A
Market Cap10.92M
Analysts80
Price Target1.33 (111.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.63
BVpS0.49
TBVpS-0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.76%
ROE -64.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.29%
FCFM N/A
ROA(3y)-20.29%
ROA(5y)-17.95%
ROE(3y)-8180.77%
ROE(5y)-4959.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.92%
GM growth 5Y-3.16%
F-Score3
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.45%
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.97
Altman-Z -0.34
F-Score3
WACC5.96%
ROIC/WACCN/A
Cap/Depr(3y)3.17%
Cap/Depr(5y)54.75%
Cap/Sales(3y)0.23%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-685.02%
EPS Next Y-300%
EPS Next 2Y-41.42%
EPS Next 3Y-9.14%
EPS Next 5Y20.78%
Revenue 1Y (TTM)-25.35%
Revenue growth 3Y-9.67%
Revenue growth 5Y-9.08%
Sales Q2Q%-40.06%
Revenue Next Year-32.64%
Revenue Next 2Y-15.43%
Revenue Next 3Y-8.31%
Revenue Next 5Y-1.34%
EBIT growth 1Y-111.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25%
EBIT Next 3Y37.95%
EBIT Next 5Y32.67%
FCF growth 1Y-106.12%
FCF growth 3Y15.2%
FCF growth 5YN/A
OCF growth 1Y-107.69%
OCF growth 3Y-38.92%
OCF growth 5YN/A